Human milk contains a high concentration of complex oligosaccharides that influence the 26 composition of the intestinal microbiota in breast-fed infants. Previous studies have indicated 27
INTRODUCTION 50
In addition to essential nutrients such as lactose lipids and proteins, human milk contains a large 51 concentration of oligosaccharides (27) . Human milk oligosaccharides (HMO) are complex and 52 diverse glycans. These molecules are composed of monomers of glucose (Glc), galactose (Gal) , 53 N-acetylglucosamine (GlcNAc), and often contain fucose (Fuc) and/or N-acetylneuraminic acid 54 (NeuAc), linked via several glycosidic bonds (38-39). All HMO contain the disaccharide lactose 55 at their reducing end. Lactose can be sialylated to form sialyllactose, or fucosylated to form 56 fucosyllactose. In more complex HMO lactose core is conjugated with repeats of lacto-N-biose I 57 (Galβ1-3GlcNAc; LNB; type-1 chain) or N-acetyllactosamine (Galβ1-4GlcNAc; type-2 chain), 58 producing molecules with a degree of polymerization larger than 4 (3). These core structures can 59 be modified by fucose and sialic acid residues via different linkages, being fucosylated neutral 60 oligosaccharides the most representative in human milk (7). Although a large number of different 61 8 (http://www.mbio.ncsu.edu/BioEdit/BioEdit.html), and checked by nucleotide-nucleotide 137 BLAST comparison at the NCBI database for species identification. 138
Multilocus sequence typing (MLST) of strains. MLST analysis of B. breve isolates targeted 139 intragenic regions of seven housekeeping genes clpC, purF, gyrB, fusA, Iles, rplB, rpoB were 140 selected based on a previous study (8) . PCR amplifications were prepared as above and cycling 141 conditions were optimized for every primer set (Table S2 ) and consisted of an initial 142 denaturation at 95 °C for 4 min, followed by 35 cycles of 95 °C for 30 s, annealing at 60-67 °C 143 for 30 s, elongation at 72 °C for 60 s, final extension at 72 °C for 7 min, and holding at 4 °C. The 144 PCR products were separated and sequenced as above. 145
Sequencing data for all loci was edited using BioEdit 7.0 and aligned using CLUSTAL W (32). 146
Phylogenetic analysis and concatenations of the sequenced loci were performed using the 147 Molecular Evolutionary Genetic Analysis (MEGA) software version 5 (http://megasoftware.net). 148
Descriptive evolutionary analysis including mol % G + C content, number of polymorphic sites, 149 nucleotide diversity π/site, average number of nucleotide differences k were calculated using 150 DnaSP version 5.10 (Table S3) . Allelic sequences were assigned as described previously (5) 151 (Table S4) . A minimum evolution tree of the concatenated loci was calculated using MEGA 5.0 152 (Fig. S1) . 153
Glycosyl hydrolase gene sequencing. α-fucosidases (Blon_2336, Blon_2335, Blon_0248/0426, 154 Blon_0346), α-sialidases (Blon_2348, Blon_0646), and β-hexosaminidase Blon_0459 protein 155 sequences from B infantis ATCC 15697 were aligned with homologous sequences from the 156 GeneBank database (Accession numbers showed in Table S5 ) using Bioedit 7.0 and degenerated9 amplified with the primers designed previously (29) to amplify the complete gene in B. infantis 160 ATCC 15697 (Table S6) . PCR amplifications were prepared as above with 200 pmol of primers 161 and cycling conditions were optimized for every primer set (Table S6) Table S1 were tested for 167 growth in the presence of seven different substrates: HMO (36), LNT, lacto-N-neotetraose 168 (LNnT), 2'-fucosyllactose (2FL), 3'-fucosyllactose (3FL) (Glycom, Denmark), 3'-sialyllactose 169 (3SL), and 6'-sialyllactose (6SL) (GenChem Inc. Korean). B. infantis ATCC 15697, and B. 170
animalis JCM 10602 were included as positive and negative control for growth in HMO, 171 respectively. Two µl of each resulting overnight culture were used to inoculate 200 µl of 172 modified MRS medium (mMRS), devoid of glucose and supplemented with 2% (w/v) of each 173 sterile-filtered substrate as the sole carbohydrate source, and another 2 µl inoculated into mMRS 174 without added sugar. The media was supplemented with 0.05% (w/v) L-cysteine, and in all the 175 cases the cultures in the wells of the microtiter plates were covered with 30 µl of sterile mineral 176 oil to avoid evaporation. The incubations were carried out at 37 ºC in an anaerobic chamber (Coy 177 Laboratory Products, Grass Lake, MI). Cell growth was monitored in real time by assessing 178 optical density (OD) at 600 nm using a BioTek PowerWave 340 plate reader (BioTek, 179 Winoosky, VT) every 30 min preceded by 15 seconds shaking at variable speed. Two biological 180 replicates and three technical replicates each were performed for every studied strain. Maximum 181 OD and growth rates were calculated and expressed as the mean of all replicates with the 182 10 respective standard deviation. These calculations were performed as previously described (4). 183
The OD obtained for each strain grown on the different substrates, was compared with the OD 184 obtained in the absence of a sugar source. This difference in OD (ΔOD) was used as a parameter 185 to evaluate each strain's ability for growing on the different substrates. where API is absolute peak intensity and n is the number of identified HMO. The consumption 218 of individual HMO species was quantitated in the same manner, in which the absolute peak 219 intensity of a specific HMO structure was normalized to the peak intensity of the corresponding 220 structure in the un-inoculated control. 221
Gene expression analysis. The full nucleotide sequences of the genes encoding a GH95 and a 222 GH29 α-fucosidase in the strain B. breve SC95 generated were used to design qPCR primers 223 using the primer-BLAST tool at NCBI (Table S6) . For relative quantification, the rnpA gene 224 protein component of ribonuclease P complex was used as in (26). B. breve SC95 was grown as 225 described above in mMRS supplemented with either 2% lactose, 2% HMO or 2% 2FL in a 226 microplate reader, and cultures were taken at mid-exponential phase OD 0.6-1.0. Samples were 227 12 immediately pelleted at 12000 x g for 1 min and stored in RNA later Ambion. RNA extraction, 228 cDNA conversion and qPCR were performed as described in (14). 229
13

RESULTS
231
Isolation and identification of Bifidobacterium from breast-fed infant feces. In order to 232 obtain a representative number of B. breve strains, we collected fecal samples from 40 breast-fed 233 term infants. Diluted fecal samples were grown on mBSM and six colonies of the higher dilution 234 were isolated. We obtained around 500 isolates that were identified at 16S level, and a total of 235 461 isolates were identified as Bifidobacterium. Seven species of bifidobacteria were detected, 236 and the species longum was found to be more represented, followed by B. breve with 77 strains 237 (Table 1) . 238
We further investigated the identity of the B. breve isolates at the strain level by MLST, as 239 described elsewhere (8). Our analysis also included nine strains from culture collections (Table  240 S1). A total of 172 single nucleotide polymorphisms (SNPs) were found in seven loci, and they 241 generated between 8 rplB and 65 purF polymorphic sites (Table S3) . Twenty different allelic 242 profiles were identified in the 86 B. breve isolates analyzed (Table S4) . Taking a conservative 243 approach, strains isolated from the unrelated infants that shared identical MLST profiles were 244 considered as separate isolates in our study. This resulted in a library of 24 strains of B. breve 245 (Table S1 ), for which a consensus phylogenetic tree of the concatenated MLST data is shown in 246 Figure S1 . 247
Glycosyl hydrolase genes in B. breve isolates. In order to study the possible adaptations of the 248 B. breve isolates for growth on HMO, we first determined the presence of three key GH classes 249 required to cleave HMO into its constituent monosaccharides. The β-galactosidase activity was 250 not examined because it is widespread in the Bifidobacterium genus. The genome of B. breve 251 UCC2003 (26) contains an α-fucosidase, an α-sialidase and a β-hexosaminidase with significant 252 homology to cognate enzymes in B. infantis ATCC 15697. No homology was found to the same 253 14 glycosyl hydrolases in B. bifidum genomes (data not shown). Based on this, we used degenerate 254 primers to look for genes encoding these GH in the assembled B. breve strains ( Table 2 OD values obtained were parameters to arbitrarily classify this panel in three groups (Table 2  266 and Table S7) . 267
In general, a moderate growth on HMO was witnessed for all the strains (Table 2, Fig. S3 and  268   Table S7 ), with strain level differences among the isolates to utilize HMO (Table 2) . 269
Interestingly, three strains (SC95, SC154 and ATCC 15701) exhibited remarkable growth on 270 HMO compared to the type strain B. breve ATCC 15700, but still lower overall growth and 271 growth rate relative to B. infantis ATCC 15697 (Fig. 1A and Table S7) . 272
All B. breve strains grew on LNT and LNnT to high cell densities and at levels comparable to B. 273 infantis ATCC 15697 (Table 2 and Fig. S4, Fig. S5 ). Interestingly, a few strains were able to 274 grow on fucosylated HMO (Fig. 1B and Table 2 ). The isolates SC95 and SC568 grew well on 275 2FL, to a similar extent than B. infantis ATCC 15697. Using 3FL as the sole carbon source, only 276 15 the strains SC95 and JCM 7019 showed minimal growth (Table 2 and Fig. S6 ). Finally, growth 277 on 3SL and 6SL was only observed for one strain, KA179 (Table 2) . 278 Table 3 shows their names, 288 masses, chemical structure, and degree of polymerization (DP). 289
Glycoprofiling
Among the six strains selected, total consumption of HMO ranged between 23 and 42%. These 290 values are lower compared to B. infantis ATCC 15697 (64% consumption) but clearly higher 291 than B. breve ATCC 15700 ( Fig. 2A) , the only B. breve strain glycoprofiled to date ((18-19, 31) . 292 Figure 3B presents the consumption of neutral non-fucosylated HMO in more detail showing 293 consumption patterns among the B. breve strains were similar. All strains were able to deplete 294 LNT/LNnT from the culture media to a high extent as previously witnessed (31). Among three 295 major hexaoses found in HMO, a preference for lacto-N-neohexaose (LNnH) was observed, over 296 lacto-N-hexaose (LNH) and para-lacto-N-hexaose (p-LNH). 297
In general, the ability of B. breve to metabolize fucosylated HMO was lower compared to B. 298 infantis, which showed high consumption levels for all the HMO tested (Fig. 3A) . However, 299 16 strains SC95, SC154 and SC568 showed a significant consumption of monofucosylated 2FL and 300 LNFPII and difucosylated DFpLNHII and DFLNH-A HMO (Fig. 3A) . Interestingly, even 301 though 2FL cannot support the growth in vitro of strain SC154 (Table 2) , this strain utilizes 302 larger fucosylated HMO. 303
We observed that growth on fucosylated HMO was more prominent in strains possessing an 304 additional GH29 α-fucosidase (Fig. 3A and Table 2 ). To determine if this gene is involved, we 305 evaluated the relative gene expression of the fucosidases in strain SC95. Growth on 2FL as the 306 sole carbon source up-regulated 40-fold the expression of the GH29 fucosidase gene (Fig. 4) , 307 while expression of the GH95 fucosidase was not altered, suggesting that the presence of the 308 GH29 fucosidase endows these strains with the ability to consume fucosylated oligosaccharides. 309
In contrast, growth on total HMO did not affect the expression of these genes. 310
Acidic HMO represents approximately 15% of total HMO, and in this study we also screened the 311 consumption of eleven sialylated HMO in the spent supernatants of these strains during growth 312 on total HMO (Fig. 3B) . The levels of consumption were very similar among the strains tested, 313 and comparable to B. infantis. In particular LSTb (sialyl-LNT b), sialyl-lacto-N-hexaose and 314 mass 4121a/4121b were preferentially utilized by B. breve (Fig. 3B) . 315
Finally, to elucidate possible substrate preferences in a B. breve strain with high HMO 316 consumption, we monitored the consumption of nine representative oligosaccharides at different 317 points during the fermentation of HMO by strain SC95 (Fig. 5) . These HMO correspond to 318 neutral and acid HMO that were consumed at levels higher than 40%. Remarkably, 319 glycoprofiling of early exponential growth revealed that acidic HMO disappeared from the 320 media first, together with LNnH. In contrast, LNT seems to be metabolized first during the mid-321 exponential phase, and as observed previously is majorly depleted at the end of the growth on 322 17 HMO. We also observed that while monofucosylated HMO as 2FL and LNFP II are depleted 323 from the media at the mid-exponential phase and not later, difucosylated HMO appear to be 324 steadily consumed during the three growth points (Fig. 5) . 325
DISCUSSION 327
B. breve is one of the most representative species of bifidobacteria found in the infant intestinal 328 microbiota. Unfortunately, the factors that contribute to this persistence in infants are not well 329 understood. We have previously determined that some B. breve strains are equipped with 330 enzymes that release N-glycans from host glycoproteins, and some strains can use N-331 glycosylated proteins as the sole carbon source (13). This suggested that glycoproteins could 332 play a prebiotic role for B. breve. In order to determine whether free HMO also contribute to the 333 persistence of B. breve in the infant intestinal microbiota we evaluated a significant number of B. 334 breve strains for growth on, and consumption of, HMO. 335
The dominance of B. breve in gut community has been supported by several studies, especially 336 in breast-fed infants (2, 28, 40) , where this species together with B. longum and B. infantis can 337 largely outnumber other microorganisms (22, 35) . It can be considered that breast milk itself is 338 also another habitat for this species, which, in addition to the vaginal and fecal microbiota of the 339 mother, contribute to intestinal colonization of the infant. (21). Some strains of this species are 340 currently studied by their probiotic properties, as for example in the production of conjugated 341 linoleic acid or important immunomodulatory activities. (16, 21, 26) . 342
Since the predominance of bifidobacteria in breast-fed infants can be attributed in part to milk 343 components such as HMO, the utilization of these substrates in vitro and in vivo is an important 344 reflection of the adaptations of intestinal microorganisms to the environmental conditions 345 prevalent in the infant gut. HMO utilization has been shown for a few Bacteroides species and 346 certain infant gut-associated bifidobacteria, especially strains of B. infantis and B. bifidum (19, 347 34 (Fig. 2A) . (25), and includes three neutral 361 isomers, LNH, LNnH and p-LNH (Table 3) . Interestingly, LNnH is the most abundant of the 362 three isomers (39) and it was selectively consumed by B. breve compared to the other two 363 isomers. This indicates structure-based preferences in HMO consumption in B. breve (Fig. 2B  364 and Table 3) . 365
Strain-dependent differences were more evident in growth of B. breve on fucosylated HMO. 366
Fucosidase activity has not been described previously in B. breve, and while all the strains 367 studied possessed a gene encoding a GH95 α-fucosidase, we observed that the presence of a 368 second α-fucosidase from GH29 in isolates SC95, SC568 and SC154 correlated with their 369 consistent growth and consumption of fucosylated HMO (Fig.3A and Table 2 ). Some strains 370 with this additional GH29 α-fucosidase however did not grow on 2FL and 3FL. We hypothesize 371 that these smaller HMO are imported by different transport mechanisms. For example, in B. Remarkably, all B. breve strains seem to consume acidic HMO to a significant extent, and an α-375 sialidase was identified. All strains glycoprofiled showed a preferential consumption of select 376 acidic HMO such as LSTb and S-LNH, but not smaller HMO, which might additionally explain 377 why growth on 3SL and 6SL was negligible (Table 2) . 378 B. infantis ATCC 15697 is currently a model to study genetic adaptations to growth on human 379 milk glycans (11). Several observations here indicate that the mechanisms of HMO consumption 380 in B. breve are very similar to B. infantis, with a preference to import intact oligosaccharides 381 followed by intracellular degradation, rather than the extracellular degradation observed by B. 382 bifidum (10). For example, B. breve strain ATCC 15700 can quickly deplete LNT from the spent 383 media and the absence of intermediate monosaccharides indicating that this strain imports this 384 substrate (1). Moreover, the GH genes identified in this study lacked signal peptides, suggesting 385 intracellular localization. Finally, the GH gene sequences obtained are homologous to previously 386 characterized enzymes in B. infantis, including β-hexosaminidases Blon_0459, two α-387 fucosidases Blon_2335 and Blon_0248 and an α-sialidase Blon_0646, suggesting a common 388 origin. Further studies will address in more detail the molecular mechanisms that B. breve 389 deploys to utilize HMO. 390
In conclusion, these results provide a rationale for the predominance of B. breve in the infant 391 intestinal microbiota, improving our understanding about the ecology of this unique 392 environment. The genetic variation of these strains and the strain-dependent character of the 393 HMO utilization, are factors to consider in probiotic and prebiotic studies. 
